Phase II trial of induction therapy with cetuximab (C225) and carboplatin/paclitaxel chemotherapy in previously untreated patients with advanced (stage IV) head and neck squamous cell carcinoma.
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2013
At a glance
- Drugs Cetuximab (Primary) ; Paclitaxel (Primary) ; Carboplatin; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 May 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 06 Jan 2011 Planned End Date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov record.